Back to results
US 2017/0246245 A1Published application
Novel pharmaceutical composition for treating alzheimer's disease
AssigneeIndustry-Academic Cooperation Foundation Gyeongsang National University
InventorMyeong Ok KIM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition, and more specifically, to a novel pharmaceutical composition for treating Alzheimer's disease including osmotin as an active ingredient.
Claims13
1-7. (canceled)
A method for improving cognitive function and memory of a subject with Alzheimer's disease, comprising administering to the subject a therapeutically effective amount of osmotin.
A method of treating or preventing Alzheimer's disease in a subject, comprising administering to the subject a therapeutically effective amount of osmotin.
Dependencies are inferred from the claim text.